giikorea.co.kr
 È¨ | ȸ»ç¼Ò°³ | ¸ÂÃãÇü ½ÃÀåÁ¶»ç | ±¹Á¦ÄÁÆÛ·±½º | ±Û·Î¹ú ÆÄÆ®³Ê | īŻ·Î±× | ¿¬¶ôó | Site Map |

Conference banner
  Page:   1  2  3   

Reports

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2010³â
The World Generic Market Report 2010
  Pub Time : 2010/01
  Published by : Espicom Business Intelligence
¼¼°è ¹× ÁÖ¿ä ±¹°¡ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í »ê¾÷ÀÇ ÁÖ¿ä °úÁ¦¤ýÁÖ¿ä µ¿Çâ, ±â¾÷ÀÇ À繫 ½ÇÀû¤ýÁ¦Ç° °³¿ä¤ýM&A µ¿Çâ, ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ±Ô¸ð, 5°³³â ¼ºÀå ¿¹Ãø, ¾àǰ °¡°Ý¤ý»óȯ µ¿Çâ, ƯÇã¤ýÁöÀû Àç»ê±Ç¿¡ °üÇÑ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

15°³ Ä¡·á ºÐ¾ß¸¦ À§ÇÑ Á¦³×¸¯ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÁ¦³×¸¯ ÀǾàǰ : ¹Ì±¹, À¯·´, ÀϺ» ¹× ±âŸ ½ÃÀåÀÇ µ¿Çâ°ú 2008¡­2013³â ¿¹Ãø
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S./ E.U./ Japan/ ROW Market Trends and Directions 2008-2013
  Pub Time : 2010/01
  Published by : Fuji-Keizai U.S.A., Inc.
Á¦³×¸¯ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÁ¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ µ¿Çâ°ú ±Ô¸ð¿¡ ´ëÇØ ºÐ¼®Çϰí, 2013³â±îÁöÀÇ 5°³³â ¿¹Ãø, ºÎ¹®º° µ¿Çâ, À¯·´, ÀϺ» µî Áö¿ªº° µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÁÖ»çÁ¦ : ½ÃÀå Àü¸Á¤ý½ÃÀå ±âȸ (¡­2014³â)
Injectable Generic Drugs: Prospects and Opportunities to 2014
  Pub Time : 2009/12
  Published by : Espicom Business Intelligence
Á¦³×¸¯ ÁÖ»çÁ¦ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ¾Ï, CNS, ½ÉÇ÷°üÁúȯ, Ç×°¨¿°Áõ, ´ç´¢º´ µîÀÇ 55°³ ÁÖ¿ä Ä¡·á¹ý ºÐ¼®, ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ 19»ç Æò°¡, 2014³â±îÁöÀÇ Á¦Ç° ¿¹Ãø, ƯÇã Á¤º¸, ½ÃÀå ¹è°æ, ÁÖ¿ä ¼Ò¼Û ¹®Á¦ÀÇ ºÐ¼® µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ¹Ì·¡ : 2015³â±îÁöÀÇ ½ÃÀå ¿¹Ãø, ±âȸ ºÐ¼® ¹× ±ÔÁ¦ µ¿Çâ
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
  Pub Time : 2009/12
  Published by : GBI Research
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇØ ¼³¸íÇÏ°í ¹Ì±¹, À¯·´, ÀϺ» ½ÃÀåÀÇ µ¿Çâ, Á¦³×¸¯ ÀǾàǰ°úÀÇ °æÇÕ, ±ÔÁ¦ µ¿Çâ ¹× ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù.

¼¼°è 7´ë ½ÃÀåÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå °³¿ä
Generics Series: Generics Overview in the Seven Major Markets
  Pub Time : 2009/12
  Published by : Datamonitor
¼¼°è 7´ë ½ÃÀå¿¡¼­ Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ ±Ô¸ð, °¡°Ý º¯µ¿, ½Å±Ô Âü°¡¼ö, ¹Ì±¹, À¯·´, ÀϺ» ½ÃÀåÀÇ ÁÖ¿ä °úÁ¦, ÁÖ¿ä ±â¾÷ÀÇ À繫 ½ÇÀû µîÀ» ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ ÀǾàǰ ½ÃÀå : 2009¡­2024³â
The US Pharmaceutical Market 2009-2024
  Pub Time : 2009/11
  Published by : Visiongain
¹Ì±¹ÀÇ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, µ¿ ½ÃÀåÀÇ ±ÔÁ¦ ȯ°æ, ÀÇ·áÁ¦µµ, º¸Çè¾÷°è µ¿Çâ, ¾à°¡ Á¦µµ, Á¤ºÎÀÇ Medicare¿Í Medicaid Á¦µµ, Á¦³×¸¯ ÀǾàǰ°ú OTC ÀǾàǰÀÇ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÀεµÀÇ ÀǾàǰ ½ÃÀå Àü¸Á : 2009¡­2024³â
Indian Pharmaceutical Market Outlook 2009-2024
  Pub Time : 2009/11
  Published by : Visiongain
Àεµ ÀǾàǰ ½ÃÀåÀÇ ÇöÀç »óȲ ¹× ¸ÅÃâ ¿¹Ãø, ½ÃÀå Á¡À¯À² ºÐ¼®, °³¹ßÁß¿¡ ÀÖ´Â ¾àÁ¦ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

À¯·´ Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ÀÚ »óÀ§ 60»çÀÇ ÇÁ·ÎÆÄÀÏ
The Top 60 European Manufacturers Of Generic Pharmaceuticals
  Pub Time : 2009/10
  Published by : Research Facts Ltd.
À¯·´ Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ÀÚ »óÀ§ 60»çÀÇ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ¿©, °¢»çÀÇ Á¶Á÷ ¹× ÀÎ»ç µ¥ÀÌÅÍ, Á¦Ç° °³¿ä ¹× Ä¡·á ºÐ¾ß, ´ë¿Ü¹«¿ª µ¿Çâ, ¸ÅÃâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦1´Ü°è ÀÌÈÄÀÇ µ¿Çâ
Biosimilars: Beyond the first product wave
  Pub Time : 2009/10
  Published by : Espicom Business Intelligence
¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Á¦Ç° °³¿ä, Á¦Á¶¾÷ÀÚ, °³¹ß µ¿Çâ, ¸ÅÃâ µ¥ÀÌÅÍ, °¢Á¾ Ȱµ¿ µîÀ» Á¦Ç° ¼¼ºÐº°·Î Á¶»ç ºÐ¼®Çϰí, ½ÃÀå °úÁ¦, Áö¿ªº° ½ÃÀå ȯ°æ ¹× µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ±â¾÷ °¡À̵å(2009³â)
Partnering in the Global Generics Industry 2009: A guide to companies
  Pub Time : 2009/10
  Published by : Espicom Business Intelligence
¼¼°è Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡¼­ÀÇ M&A Èĺ¸ ¹× Á¦ÈÞ ÆÄÆ®³Ê °áÁ¤¿¡ µµ¿òÀ» µå¸± ¼ö ÀÖµµ·Ï ¼¼°è 40°³±¹ Áß±Ô¸ð Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ÀÚ 170»çÀÇ °¢Á¾ ±â¾÷ µ¥ÀÌÅ͸¦ ±¹°¡º°·Î ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå(2009¡­2014³â)
Biosimilars (2009 - 2014)
  Pub Time : 2009/09
  Published by : Markets and Markets
¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Ç°¡¤¼­ºñ½º ½ÃÀåÀÇ °³¿ä ¹× ÀÀ¿ë ºÐ¾ß, ±â¼ú µ¿Çâ, ½ÃÀå µ¥ÀÌÅÍ, ÁÖ¿ä ±â¾÷, °æÇÕ Àü¸Á µîÀ» ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰÀÇ ¼ºÀå Àü·« : ºñ¿ë ¾ïÁ¦Ã¥°ú M&A¿¡ µû¸¥ ¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ¾÷°èÀÇ È®¸³
Generics Growth Strategies: Cost containment and M&A shape the global generics industry
  Pub Time : 2009/09
  Published by : Business Insights
ºê·£µåÈ­ µÇÁö ¾ÊÀº Á¦³×¸¯ ÀǾàǰ ¾÷°è¸¦ Á¤¼ºÀû, Á¤·«ÀûÀ¸·Î ºÐ¼®Çϰí ÁÖ¿ä Á¦Á¶»ç 10»çÀÇ ¸ÅÃâ ½ÇÀû, ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç ±¹°¡, ¶óƾ ¾Æ¸Þ¸®Ä« ±¹°¡ÀÇ Áö¿ªº° µ¿Çâ, 2005³â ÀÌÈÄÀÇ ÁÖ¿ä M&A¸¦ ¼Ò°³Çص帳´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå°ú ¹Ì±¹ÀÇ ÈÄ¼Ó »ý¹°Á¦Á¦ÀÇ °¡´É¼º
The World Market for Biosimilars and the Potential for US Follow-on Biologics
  Pub Time : 2009/08
  Published by : Kalorama Information
¼¼°è °¢±¹ ¹ÙÀÌ¿ÀÁ¦³×¸¯ ½ÃÀåÀÇ ÇöÀç ±Ô¸ð ¹× ¿¹Ãø, ƯÇã°¡ ¸¸·áµÈ »ý¹°Á¦Á¦¿Í ƯÇã±â°£ ÁßÀÎ ¾àÁ¦, ¹ÙÀÌ¿ÀÁ¦³×¸¯ÀÇ ÁÖ¿ä °æÇÕ ÇÁ·ÎÆÄÀÏ, FDA¿Í EMEAÀÇ ±ÔÁ¦ µ¿Çâ, ¹Ì±¹ ½ÃÀåÀÇ ÇâÈÄ ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå
Booming US Generic Drug Market
  Pub Time : 2009/08
  Published by : RNCOS E-Services Pvt. Ltd.
¹Ì±¹ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¤º¸¸¦ Á¦°øÇϰí, À§Å¹ Á¦Á¶ ¹× ¹ÙÀÌ¿À Á¦³×¸¯ ÀǾàǰ µîÀÇ ½ÅÈï µ¿Çâ, ½ÃÀå ±Ô¸ð, ¼ºÀå, ±ÔÁ¦ ȯ°æ, ±â¼ú °³¹ßÀÇ µ¿Çâ µîÀ» ÀÚ¼¼È÷ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹æÃâÁ¦¾îÇü Á¦³×¸¯ ÀǾàǰÀÇ »õ·Î¿î ±âȸ
Emerging Opportunities in Controlled-Release Generic Drugs
  Pub Time : 2009/08
  Published by : Espicom Business Intelligence
ÁÖ¿ä Ä¡·á ºÐ¾ß¿¡¼­ÀÇ 30°³ ¹æÃâÁ¦¾î Á¦Á¦ÀÇ ÇöȲ ¹× Àå·¡¼º, µ¿ ºÐ¾ß¿¡ Âü°¡ÇÑ ±â¾÷ 13»çÀÇ ÇÁ·ÎÆÄÀÏ, µ¿ ºÐ¾ß¿¡¼­ÀÇ Á¦³×¸¯ ÀǾàǰÀÇ ÇâÈÄ Àü¸Á¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

½ÅÈï ½ÃÀåÀÇ Á¦³×¸¯ ÀǾàǰ Àü·«
Generic Strategies in Emerging Markets
  Pub Time : 2009/08
  Published by : Datamonitor
ÁßÀ¯·´, µ¿À¯·´ ¹× ¶óƾ ¾Æ¸Þ¸®Ä«ÀÇÁ¦³×¸¯ ÀǾàǰ ½ÃÀå µ¿Çâ°ú ÁÖ¿ä À庮 ¹× ±âȸ, Áö¿ªÀÇ ±¹³» Á¦Á¶»ç, ÇØ¿Ü Á¦Á¶»çÀÇ µ¿Çâ°ú ÇâÈÄ ½ÃÀå Âü°¡¤ýÈ®´ë Àü·«À» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2009¡­2024³â
World Generics Market 2009-2024
  Pub Time : 2009/08
  Published by : Visiongain
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ¸ÅÃâ ¿¹Ãø°ú ±¹°¡º° ½ÃÀåÀ» Á¤¼ºÀû, Á¤·®ÀûÀ¸·Î ºÐ¼®ÇÏ°í Æ¯È÷ ¹Ì±¹, À¯·´, ÀϺ», Áß±¹, Àεµ, ·¯½Ã¾Æ¿¡ ÃÊÁ¡À» ¸ÂÃß¾î 2024³â±îÁö ¿¹ÃøÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ij³ª´ÙÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2009³âÆÇ
Generic Drug Market in Canada
  Pub Time : 2009/08
  Published by : RNCOS E-Services Pvt. Ltd.
ij³ª´ÙÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ ÀǾàǰ ½ÃÀå Àüü °³¿ä, Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ ±Ô¸ð, ¼ºÀå, ½ÃÀå ±¸ºÐ, ½ÃÀå ¿¹ÃøÀ» µîÀ» ºÐ¼®Çϰí, ½ÃÀåÀÇ ¸Å·Â ¹× ±âȸ ºÐ¾ß, »ê¾÷ÀÇ Àå¾Ö¿äÀÎ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯¿Í ¹ÙÀÌ¿Àº£Å¸ : »õ·Î¿î ½ÃÀåÀ» ÇâÇÑ Æ÷Áö¼Å´×
Biosimilars and Biobetters: Positioning for a New Market
  Pub Time : 2009/07
  Published by : Biophoenix Limited
Á¦1, Á¦2 ¼¼´ëÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí Ãâ½Ã ¿Ï·á ¹× °³¹ßÁß¿¡ ÀÖ´Â Çõ½ÅÀû ¹ÙÀÌ¿À½Ã¹Ð·¯ µ¿Çâ, EUÀÇ ±ÔÁ¦, ¹Ì±¹ÀÇ °³¹ß µ¿Çâ, ¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ °³¹ß ±â¾÷ 40»ç ÇÁ·ÎÆÄÀÏ ¹× ±¹°¡º° ¿¹Ãø µîÀ» ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå
Generic Drugs: The Global Market
  Pub Time : 2009/07
  Published by : BCC Research
¼¼°è Á¦³×¸¯ ÀǾàǰÀÇ 2014³â±îÁöÀÇ ¸Å»ó ¿¹Ãø, Á¦³×¸¯ ÀǾàǰÀÇ Ç¥ÀûÀÌ µÇ°í Àִ ó¹æ¾àÀÇ ÁÖ¿ä Ä«Å×°í¸® ¸®ºä, ¹Ì±¹, EU, ÀϺ»¿¡¼­ÀÇ Á¦³×¸¯ ÀǾàǰ Á¦Á¶ ¹× ¸¶ÄÉÆÃ¿¡ °üÇÑ ±ÔÁ¦ ȯ°æ ºÐ¼®, ÁÖ¿ä °ø±ÞÀÚ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯¾àǰ ¹ß¸Å : °øÀÎ Á¦³×¸¯ ÀǾàǰ ºÐ¼®
Generics Series: Authorized Generics Analysis
  Pub Time : 2009/07
  Published by : Datamonitor
°øÀÎ Á¦³×¸¯¾à ½ÃÀåÀÇ °³¿ä¤ý°è¾à µ¿Çâ¤ý½ÃÀåÀ¸·ÎÀÇ Ä§½Ä µ¿Çâ µîÀ» Á¶»ç ºÐ¼®ÇÏ°í °øÀÎ Á¦³×¸¯¾à¿¡ °üÇÑ °è¾à¼öÀÇ ÃßÀÌ, °øÀÎ Á¦³×¸¯¾àÀÇ Ãâ½Ã ÈÄ ½ÃÀå Á¡À¯À² ÃßÀÌ, ½ÃÀå Á¡À¯À² È®´ëÀÇ ºê·£µå °¡Ä¡¤ýÄ¡·á ºÎ¹®¤ýÅõ¾à ÇüÅÂÀÇ ¿µÇâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ ½Ã¸®Áî : ¿¹Ãø ºÐ¼®
Biosimilars Series: Forecast Analysis
  Pub Time : 2009/06
  Published by : Datamonitor
¼¼°è 7´ë ½ÃÀåÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ µ¿Çâ ¿¹Ãø, °¢Á¾ ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ÇöÀç »óȲ ºÐ¼® ¹× ÇâÈÄ Àü¸ÁÀ» ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ ±â¾÷ »óÀ§ 10»ç : Æ÷Áö¼Å´×, ½ÇÀû ¹× SWOT ºÐ¼®
The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
  Pub Time : 2009/04
  Published by : Business Insights
¼¼°è ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÀÇ °æÇÕ È¯°æ, ÀÌ ºÐ¾ßÀÇ ÁÖ¿ä ¹®Á¦Á¡ ¹× ÁøÈ­ÇÏ´Â ºñÁî´Ï½º ¸ðµ¨, ´ëÇü Âü°¡±â¾÷ ÇÁ·ÎÆÄÀÏ, »óÀ§ 10»çÀÇ Æ÷¸£Æú¸®¿À ÆÇ¸Å ½ÇÀû, ÆÄÀÌÇÁ¶óÀÎ, ¼ºÀå Àü·«, °¢»ç°¡ ¸Â°Ô µÉ ±âȸ ¹× À§Çù¿¡ ´ëÇØ ºÐ¼®Çϰí, ¼¼°è ¹ÙÀÌ¿À½Ã¹Ð·¯ »ê¾÷ ÀüüÀÇ ±Ô¸ð, ¼ºÀ强, ÁÖ¿ä µ¿Çâ, »óÀ§ 10»çÀÇ µÚ¸¦ ÀÕ°í ÀÖ´Â ÁÖ¿ä Á¦Á¶»ç¿¡ ´ëÇÑ Æò°¡ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯¿Í ÈÄ¼Ó »ý¹°Á¦Á¦ : ¼¼°è ½ÃÀå Àü¸Á(2009¡­2024³â)
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
  Pub Time : 2009/04
  Published by : Visiongain
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÀÇ 2009¡­2024³â ¿¹Ãø, ÇâÈÄ 15³â°£ »ó¾÷Àû ¼º°øÀ» °ÅµÑ Àü¸ÁÀÎ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀǾàǰ ¹× Á¦Á¶»ç¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰ °¡°ÝÀÇ ¿¹Ãø ¹æ¹ý
How to Forecast Generic Pharmaceutical Prices
  Pub Time : 2009/03
  Published by : Urch Publishing, Ltd.
Ãâ½Ã Àü ¹× Ãâ½Ã ÈÄÀÇ ÇâÈÄ Á¦³×¸¯ ÀǾàǰ °¡°Ý ÃßÀÌ ¿¹Ãø ¹æ¹ýÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿ÀÆÄ¸¶ : 2008³â Á¦4»çºÐ±âÀÇ ÁÖ¿ä µ¿Çâ°ú À̺¥Æ®
Biopharma Quarter: Key Trends and Events of the Fourth Quarter of 2008
  Pub Time : 2009/03
  Published by : Decision Resources, Inc.
¹Ì±¹ ¹× ¿µ±¹ÀÇ Á¤Ä¡ º¯Çõ°ú °æÁ¦ ºÒȲÀÌ ¹ÙÀÌ¿ÀÆÄ¸¶ ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ, °¢±¹ÀÇ Á¦³×¸¯ ÀǾàǰ ħÅõ µ¿Çâ, ÀϺ»ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ¾÷°è ¹× Áß±¹ÀÇ ÁöÀû Àç»ê µ¿Ç⠵ ´ëÇÑ Àü¹®°¡ÀÇ °ßÇØ¸¦ ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ º¥Ä¡¸¶Å· : ƯÇã ¸¸·á¿¡ µû¸¥ ºê·£µå ÀǾàǰÀÇ ¾àüȭ
Generic Benchmarking: Brand Erosion at Patent Expiry
  Pub Time : 2009/03
  Published by : Datamonitor
ÁÖ¿ä 7´ë ½ÃÀå¿¡¼­ÀÇ ºê·£µå ÀǾàǰÀÇ ¾àüȭ¿¡ ´ëÇØ ºÐ¼®Çϰí, Á¦³×¸¯ ÀǾàǰÀÇ °¡°Ý °³¿ä, »ç·Ê¿¬±¸ µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ : ±ÔÁ¦ ȯ°æÀÇ ÁÖ¿ä °³¹ß µ¿Çâ
Negotiating the Emerging Biosimilars Landscape: Key developments in the regulatory environment
  Pub Time : 2009/02
  Published by : Business Insights
»ý¹° Á¦Á¦ ¾÷°èÀÇ ±¸Á¶ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀåÀÌ ÁÖ´Â À§Çù¿¡ ´ëÇÑ Àü·«Àû ¾îÇÁ·ÎÄ¡, ½ÃÀå ¾×¼¼½º ¿µÇâ ¿äÀÎ, »ý¹°ÇÐÀû µ¿µî¼ºÀ» µÑ·¯½Ñ Ãֽе¿Çâ°ú ÇÔ²² Áö¿ªº° ±ÔÁ¦ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÀϺ»ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2013³â±îÁöÀÇ ¿¹Ãø
Japanese Generic Market Forecast to 2013
  Pub Time : 2009/01
  Published by : RNCOS E-Services Pvt. Ltd.
ÀϺ»ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀ» ºÐ¼®Çϰí ÀϺ»ÀÇ Á¦¾à ½ÃÀå ÇöÀç »óȲ°ú Á¦³×¸¯ ÀǾàǰÀÇ ¼ºÀå ¿äÀÎ, ¼ºÀåÀÇ Àå¾Ö µîÀ» ´Ù°¢ÀûÀ¸·Î ºÐ¼®ÇÏ¿© ÁÖ¿ä ±â¾÷ÀÇ Á¤º¸¿Í ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

À¯·´ÀÇ ½ÅÈï Á¦³×¸¯ ÀǾàǰ ½ÃÀå
Emerging Generic Pharmaceuticals Markets in Europe
  Pub Time : 2008/12
  Published by : Frost & Sullivan
À¯·´ Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ ¼ºÀå ±âȸ¿¡ ´ëÇØ ºÐ¼®Çϰí, ¾÷°è Âü°¡±â¾÷ÀÌ Á÷¸éÇÑ °úÁ¦, ¼öÀÍ ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

7´ë ½ÃÀåÀÇ Á¦³×¸¯ ÀǾàǰ µ¿Çâ
Generics Series: Generics Trends in the Seven Major Markets and Beyond
  Pub Time : 2008/12
  Published by : Datamonitor
¼¼°è ÀǾàǰ 7´ë ½ÃÀåÀÇ Á¦³×¸¯ ÀǾàǰ ¾÷°è¿¡ ´ëÇÑ ÁÖ¿ä À̺¥Æ®, °æÇÕ·Â À¯Áö¸¦ À§ÇÑ Àü·«Àû µ¿Çâ, ÃÖ±ÙÀÇ M&A µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2008¡­2013³â
World Generics Market, 2008-2013
  Pub Time : 2008/11
  Published by : Visiongain
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå °³¿ä¿Í 2008¡­2013³âÀÇ ¸ÅÃâ ¿¹Ãø, ¹Ì±¹, ÀϺ», À¯·´À» Æ÷ÇÔÇÑ Áö¿ªº° µ¿Çâ ¹× ÇâÈÄÀÇ ±âȸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯ Á¦Á¶»óÀÇ °úÁ¦ ±Øº¹
Meeting the Challenges of Manufacturing Biosimilars
  Pub Time : 2008/11
  Published by : Decision Resources, Inc.
¹ÙÀÌ¿À½Ã¹Ð·¯¿¡ ´ëÇÑ °¢±¹ÀÇ ±ÔÁ¦ µ¿Çâ, ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ Á¦Á¶»óÀÇ °úÁ¦, Á¦2¼¼´ë ¹ÙÀÌ¿ÀÀÇ·á, ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ¸¶ÄÉÆÃ, Âü°¡±â¾÷ÀÇ µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰ : ¼¼°èÀÇ »ê¾÷ °¡À̵å
Generics: Global Industry Guide
  Pub Time : 2008/11
  Published by : Datamonitor
¼¼°è ¹× ÁÖ¿ä Áö¿ª/±¹°¡ÀÇ Á¦³×¸¯ ÀǾàǰ »ê¾÷ µ¿ÇâÀ» Á¶»ç ºÐ¼®Çϰí, ½ÃÀå±Ô¸ðÀÇ ½ÇÀû ¹× ¿¹Ãø(¡­2012³â), °Å½Ã°æÁ¦ ÁöÇ¥, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰÀÇ Ä§½Ä : 2008³â
SPECIAL REPORT: Patterns of Generic Erosion: An International Chartbook, 2008
  Pub Time : 2008/10
  Published by : Decision Resources, Inc.
Á¦³×¸¯ ÀǾàǰÀÇ °³¿ä ¹× ºê·£µå ÀǾàǰ°úÀÇ °æÇÕ, ºê·£µå ÀǾàǰ ½ÃÀåÀ¸·ÎÀÇ Ä§½Ä, ÀǾàǰ ¾÷°èÀÇ ÇâÈÄ Àü¸Á°ú ÇÔ²² ¹Ì±¹, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹ ¹× ÀϺ» °¢±¹ÀÇ µ¿ÇâÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

ÈíÀÔ½Ä ¹× ºñ°­ ºÐ¹«½Ä Á¦³×¸¯ ÀǾàǰÀÇ »õ·Î¿î ½ÃÀå ±âȸ
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2008
  Pub Time : 2008/10
  Published by : Espicom Business Intelligence
ÈíÀÔ½Ä ¹× ºñ°­ ºÐ¹«½Ä ÀǾàǰÀÇ Æ¯Çã µ¿Çâ, ½ÃÀå Àü¸Á µîÀ» ±¸ºÐº°·Î Á¶»ç ºÐ¼®ÇÏ°í ¸ÅÃâ ½ÇÀû¤ý¿¹Ãø(¡­2013³â), Á¦³×¸¯ ÀǾàǰÀÇ ½ÃÀå ±âȸ, FDA ½ÂÀÎ µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

À¯·´ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå Àü¸Á
European Biosimilars Market Outlook
  Pub Time : 2008/09
  Published by : Frost & Sullivan
À¯·´ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå¿¡ ´ëÇØ °£·«È÷ ¼³¸íÇϰí EUÀÇ ±ÔÁ¦ µ¿Çâ, °úÁ¦ µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ±¹°¡º°, ºÎ¹®º° ±âȸ ºÐ¼® µî°ú ÇÔ²² ÀüÇØµå¸³´Ï´Ù.

¹ÙÀÌ¿À ½Ã¹Ð·¯ : ½ºÅ×ÀÌÅ© Ȧ´õ ºÐ¼®
Biosimilars Series: Stakeholder Analysis
  Pub Time : 2008/08
  Published by : Datamonitor
¹ÙÀÌ¿À ½Ã¹Ð·¯¿¡ ´ëÇÑ ÃËÁøÀÎÀÚ ¹× ÀúÇØÀÎÀÚÀÇ °³¿ä, À¯·´ ¹× ¿µ±¹ÀÇ ½ºÅ×ÀÌÅ© Ȧ´õ °³¿ä, ¹ÙÀÌ¿À ½Ã¹Ð·¯ÀÇ À̿뿡 °üÇÑ ÀÇ»ç ¹× ¾àÁ¦»ç µîÀÇ °ßÇØ, ¾÷°èÀÇ ¹ßÀü µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.

Á¦³×¸¯ ÀǾàǰ Á¦Á¶ »óÀ§ 10 ±â¾÷ : ÁöÀ§, ½ÇÀû, SWOT ºÐ¼®
The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
  Pub Time : 2008/07
  Published by : Business Insights
Á¦³×¸¯ ÀǾàǰ ¾÷°èÀÇ °³¿ä¿Í ÇÔ²² ½ÃÀå ±Ô¸ð¿Í ¼ºÀå, ÇöÀçÀÇ µ¿Çâ°ú ¼¼°èÀÇ ¼ºÀå Àü¸Á ¹× ¹Ì±¹°ú EUÀÇ Á¦³×¸¯ ÀǾàǰ ¾÷°è °æÇÕ µ¿Çâ µîÀ» ÀüÇØµå¸³´Ï´Ù.

°æÇÕÁßÀÎ Á¦³×¸¯ ½ÃÀå¿¡¼­ÀÇ ¼öÀÍ ÃÖ´ëÈ­¸¦ À§ÇÑ ºê·£µå ¼ö¸íÁֱ⠰ü¸® Àü·«
Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition
  Pub Time : 2008/07
  Published by : Datamonitor
¼ö¸íÁֱ⠰ü¸®°¡ Áß¿äÇÑ ÁÖ¿ä ÀÌÀ¯, ¼ö¸íÁֱ⠰ü¸® Àü·« ¼ö¸³½Ã¿¡ ÁÖÀÇÇØ¾ß ÇÒ °úÁ¦, ÀϹÝÀûÀÎ ¼ö¸íÁֱ⠰ü¸® Àü·«, ÄÉÀ̽º½ºÅ͵ð µî¿¡ ´ëÇØ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¹Ì±¹ÀÇ ÀǾàǰ ½ÃÀåÀÇ º¯È­
All change in the US Pharma Market?
  Pub Time : 2008/06
  Published by : Espicom Business Intelligence
¹Ì±¹ÀÇ ÀǾàǰ ½ÃÀåÀÇ Á¦³Ê¸¯ ÀǾàǰ°úÀÇ °æÇÕ µ¿Çâ¿¡ ´ëÇØ ºÐ¼®ÇÏ°í ±ÝÈÄ 5³â°£ÀÇ ¿¹Ãø, 14°³ ºê·£µå ÀǾàǰ ±â¾÷¿¡°Ô ¹ÌÄ¡´Â ¿µÇâ, Àå·¡ ±â¾÷ Àü·« µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿À Á¦³×¸¯ ÀÇ¾à ½ÃÀå
Biogenerics: The World Market for Biosimilars
  Pub Time : 2008/04
  Published by : Kalorama Information
ƯÇã°¡ ½ÇÈ¿¼º ÀÖ´Â ÁÖ¿ä »ý¹°Á¦Á¶ ¹× Á¦³×¸¯ÀǾàÀÇ °æÇÕ¿¡ ´ëÇØ ºÐ¼®ÇÏ°í ¹ÙÀÌ¿À Á¦³×¸¯ ÀÇ¾à ½ÃÀåÀÇ ±Ô¸ð, µ¿Çâ, ±ÔÁ¦ ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ó¹æ¾à ½ÃÀå : Á¦6ÆÇ
World Market for Prescription Generic Drugs, 6th Edition
  Pub Time : 2008/04
  Published by : Kalorama Information
Á¦³×¸¯ ÀǾàǰ ½ÃÀå ±Ô¸ð ¹× 2012³â±îÁöÀÇ ¿¹Ãø, ¼¼°è ¹× ¹Ì±¹ÀÇ ½ÃÀå Á¡À¯À² ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÁßÃ߽Űæ°è Á¦³×¸¯ ÀǾàǰ : 2012³â±îÁöÀÇ Àü¸Á ¹× ±âȸ
CNS Generic Drugs: Prospects and Opportunities to 2012
  Pub Time : 2008/04
  Published by : Espicom Business Intelligence
ÁßÃ߽Űæ°è Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®Çϰí, ÁÖ¿ä ¾àÁ¦ÀÇ 2012³â±îÁöÀÇ ¸ÅÃâ ¿¹Ãø°ú 2015³â±îÁöÀÇ Æ¯Çã ½ÇÈ¿ µ¿Çâ ¹× °æÇÕ µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

¿À½ºÆ®·¹Àϸ®¾ÆÀÇ Á¦³×¸¯ ÀǾàǰ ±âȸ ¹× °úÁ¦
Opportunities and Challenges for Generic Drugs in Australia
  Pub Time : 2008/03
  Published by : Espicom Business Intelligence
¿À½ºÆ®·¹Àϸ®¾ÆÀÇ ±¹°¡ Á¤º¸ ¹× ÀÇ·á Á¦µµÀÇ °³¿ä, Á¦³×¸¯ ÀǾàǰ ½ÃÀå µ¿Çâ, ÇâÈÄ ¿¹Ãø ¹× ÁÖ¿ä ±â¾÷ µîÀ» ÀüÇØµå¸³´Ï´Ù.

ÀεµÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : 2008-2012³â
Indian Generics, 2008-2012 The Growing Threat to Westernised Markets
  Pub Time : 2008/03
  Published by : Arrowhead Publishers
Àεµ ÀǾàǰ »ê¾÷ÀÇ ¹è°æ, ÀÇ·áÁ¦µµ, ¾à»ç°ü·Ã¹ý, ÀǾàǰ ½ÃÀåÀÇ ±Ô¸ð µî¿¡ ´ëÇØ Á¶»çºÐ¼®Çϰí, ÀεµÀÇ Á¦³×¸¯ ÀǾàǰ »ê¾÷ ¼ºÀå µ¿Çâ, ÇØ¿ÜÀÇ ±âÁ¸ Á¦³×¸¯ ÀǾàǰ ±â¾÷¿¡ ´ëÇÑ ¿µÇâ(À§Çù), ÀεµÀÇ ÁÖ¿ä ±â¾÷°ú Àü¹® ºÐ¾ß µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : ÁÖ¿ä ±â¾÷ ºÐ¼®¡¤½ÃÀå ºÐ¼®¡¤½ÃÀå ¿¹Ãø(2007-2012³â¡¤2017³â¡¤2022³â)
Generic League - Market Analysis and Forecasts, 2007-2012, 2017 & 2022
  Pub Time : 2008/02
  Published by : Visiongain
¼¼°è Á¦³×¸¯ ÀǾàǰ ½ÃÀå ÁÖ¿ä ±â¾÷ 10»çÀÇ È¸»ç °³¿ä, ¼öÀÍ¡¤½ÃÀå Á¡À¯À² ½ÇÀû, ¼öÀÍ ¿¹Ãø(2007-2012³â¡¤2017³â¡¤2022³â), Á¦Ç° °³¿ä, ±â¾÷ Àü·«, ±â¾÷ Á¦ÈÞ¡¤¸Å¼ö µ¿Ç⠵ ´ëÇØ Á¶»çºÐ¼®Çϰí, ¼¼°è ¹× Áö¿ªº° ½ÃÀåÀÇ µ¿Çâ, À¯·´ ¹× ¹Ì±¹ÀÇ °ü·Ã ±ÔÁ¦ µîµµ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¾Æ½Ã¾ÆÀÇ Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü
Generics Producers in Asia: Where Are the Big Opportunities
  Pub Time : 2008/02
  Published by : Business Monitor International
¾Æ½Ã¾Æ 14°³±¹ Á¦³×¸¯ ÀǾàǰ Á¦Á¶¾÷ü 50»çÀÇ ÇÁ·ÎÆÄÀÏ, ¾÷°è µ¿Çâ ¹× ¼ºÀå Àü¸Á, ÇâÈÄ 2012³â±îÁöÀÇ 5³â°£ ¿¹Ãø, °æÇÕ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

À¯·´ÀÇ »õ·Î¿î Á¦³×¸¯ ÀǾàǰ ½ÃÀå
Emerging Generic Drug Markets in Europe
  Pub Time : 2007/12
  Published by : Espicom Business Intelligence
ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ½ºÆäÀÎÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÏ°í °¢±¹ÀÇ ÀÇ·á Á¦µµ, ÀÇ·á ÀÎÇÁ¶ó, ÀÇ·á/ÀǾàǰ ½ÃÀåÀÇ ±Ô¸ð, Á¦³×¸¯ ÀǾàǰÀÇ ½ÃÀå¿¹Ãø(2007-2012³â)¤ýSWOT ºÐ¼®¤ýÀÚ±¹ Á¦Á¶¾÷ÀÚÀÇ µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

ÁÖ¿ä 7°³±¹ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå
Generics Series: Key trends and events in the 7 major markets
  Pub Time : 2007/12
  Published by : Datamonitor
¹Ì±¹, ÀϺ», ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹ÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå µ¿Çâ ¹× »ç°Ç, ±ÔÁ¦ ȯ°æ, ºñÁî´Ï½º ȯ°æ, ÁÖ¿ä ÀÌÇØ°ü°èÀÚÀÇ È°µ¿°ú ±× ¿µÇâ, ½ÃÀ强Àå °ßÀοäÀÎ/ÀúÇØ¿äÀÎ, M&A µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.

  Page:   1  2  3   


| Home | Contact | E-mailing | About GII | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§| Site Map |
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç
Tel:02-2025-2992, Fax:02-2025-2993, E-mail :
(C) Copyright 2009, Global Information, Inc. All rights reserved.